Data Supplement
- Supplemental Data -
Supplemental Figure 1 - Schematic representation (not to scale) of the treatment protocol
Supplemental Figure 2 - Western Blot verification of differential expression of the CAR targets in normal liver (NL) and in mouse liver tumors with activating mutations in either Ha-ras (Ras) or B-raf (Raf)
Supplemental Figure 3 - CAR mRNA levels in normal liver (NL) and mouse liver tumors with activating mutations in either Ha-ras (Ras) or B-raf (Raf)
Supplementary Table 1 - Antibodies used for RPPA assay